Gabriella D'Orazi

39PUBLICATIONS
20CO-AUTHORS
Molecular targetsFree radical chemistryPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Biomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|May 27, 2026
Correction: Di Crosta et al. Valemetostat-SAHA-Driven Acetylation of p53 via SET/TAF-Iβ Displacement and p300 Activation Modulates Cell Cycle Regulators in Pancreatic Cancer Cells. <i>Biomedicines</i> 2025, <i>13</i>, 2279.

|May 27, 2026
The Oxidative Stress: Origin and Role in Aging and Diseases.

|Sep 27, 2025
Valemetostat-SAHA-Driven Acetylation of p53 via SET/TAF-Iβ Displacement and p300 Activation Modulates Cell Cycle Regulators in Pancreatic Cancer Cells.

Michele Di Crosta, Francesca Chiara Ragone, Rossella Benedetti

|Jul 27, 2024
HIPK2 in Colon Cancer: A Potential Biomarker for Tumor Progression and Response to Therapies.

Alessandra Verdina, Alessia Garufi, Valerio D'Orazi

|Jul 26, 2024
Post-Translational Modifications (PTMs) of mutp53 and Epigenetic Changes Induced by mutp53.

Rossella Benedetti, Michele Di Crosta, Gabriella D'Orazi

|Jul 13, 2024
SAHA/5-AZA Enhances Acetylation and Degradation of mutp53, Upregulates p21 and Downregulates c-Myc and BRCA-1 in Pancreatic Cancer Cells.

Michele Di Crosta, Francesca Chiara Ragone, Rossella Benedetti

Pageof 7

Frequent Collaborators

27 joint publications

Mara Cirone

14 joint publications

Maria Saveria Gilardini Montani

9 joint publications

Rossella Benedetti

5 joint publications

Roberta Santarelli